ZA997138B - Erysipelothrix rhusiopathiae antigens and vaccine compositions. - Google Patents

Erysipelothrix rhusiopathiae antigens and vaccine compositions.

Info

Publication number
ZA997138B
ZA997138B ZA9907138A ZA997138A ZA997138B ZA 997138 B ZA997138 B ZA 997138B ZA 9907138 A ZA9907138 A ZA 9907138A ZA 997138 A ZA997138 A ZA 997138A ZA 997138 B ZA997138 B ZA 997138B
Authority
ZA
South Africa
Prior art keywords
vaccine compositions
erysipelothrix rhusiopathiae
antigens
rhusiopathiae antigens
erysipelothrix
Prior art date
Application number
ZA9907138A
Other languages
English (en)
Inventor
David Stewart Roberts
Leroy Allen Swearingin
Brian Thomas Suiter
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA997138B publication Critical patent/ZA997138B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
ZA9907138A 1999-01-29 1999-11-16 Erysipelothrix rhusiopathiae antigens and vaccine compositions. ZA997138B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11770499P 1999-01-29 1999-01-29

Publications (1)

Publication Number Publication Date
ZA997138B true ZA997138B (en) 2001-05-16

Family

ID=22374369

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9907138A ZA997138B (en) 1999-01-29 1999-11-16 Erysipelothrix rhusiopathiae antigens and vaccine compositions.

Country Status (17)

Country Link
EP (1) EP1027895B1 (ja)
JP (3) JP3535436B2 (ja)
CN (1) CN1210062C (ja)
AR (1) AR020022A1 (ja)
AT (1) ATE386540T1 (ja)
AU (1) AU776847B2 (ja)
BR (1) BR9905853B1 (ja)
CA (1) CA2290078C (ja)
CY (1) CY1107910T1 (ja)
DE (1) DE69938168T2 (ja)
DK (1) DK1027895T3 (ja)
ES (1) ES2301230T3 (ja)
HK (1) HK1029062A1 (ja)
NZ (1) NZ501128A (ja)
PT (1) PT1027895E (ja)
TW (1) TW546146B (ja)
ZA (1) ZA997138B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8637047B2 (en) * 2003-10-30 2014-01-28 Boehringer Ingelheim Vetmedica, Inc. Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
CN107496913A (zh) * 2017-09-15 2017-12-22 天津瑞普生物技术股份有限公司 猪丹毒、猪细小病毒、猪流感病毒三联灭活疫苗制备方法
CN107648599A (zh) * 2017-09-18 2018-02-02 天津瑞普生物技术股份有限公司 一种猪丹毒、猪细小病毒二联灭活疫苗的制备方法
CN110812473A (zh) * 2019-12-10 2020-02-21 广东君睿生物技术研究有限公司 一种副猪嗜血杆菌病、猪链球菌病和猪多杀性巴氏杆菌病三联灭活疫苗及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0294071A3 (en) * 1987-06-03 1990-08-01 Merck & Co. Inc. Hepatitis b vaccines made with pre-formed aluminum hydroxide gels, and processes thereof
US5695769A (en) * 1990-06-13 1997-12-09 Pfizer Inc. Pasteurella multocida toxoid vaccines
CA2123222C (en) * 1991-11-15 2001-02-27 Donald A. Dearwester Gram-negative bacterial vaccines
US5690942A (en) * 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines
JP3072345B1 (ja) * 1999-03-31 2000-07-31 農林水産省家畜衛生試験場長 豚丹毒菌の組換えサブユニットワクチン

Also Published As

Publication number Publication date
BR9905853A (pt) 2000-11-14
DE69938168T2 (de) 2009-02-26
NZ501128A (en) 2001-12-21
DK1027895T3 (da) 2008-06-09
JP2003160507A (ja) 2003-06-03
AR020022A1 (es) 2002-03-27
CA2290078C (en) 2013-01-22
AU776847B2 (en) 2004-09-23
JP2000219637A (ja) 2000-08-08
JP3535436B2 (ja) 2004-06-07
BR9905853B1 (pt) 2011-11-01
CN1210062C (zh) 2005-07-13
JP2007119499A (ja) 2007-05-17
AU5944599A (en) 2000-08-03
CA2290078A1 (en) 2000-07-29
HK1029062A1 (en) 2001-03-23
CN1262129A (zh) 2000-08-09
EP1027895A2 (en) 2000-08-16
JP4714167B2 (ja) 2011-06-29
EP1027895B1 (en) 2008-02-20
EP1027895A3 (en) 2001-07-18
ATE386540T1 (de) 2008-03-15
TW546146B (en) 2003-08-11
DE69938168D1 (de) 2008-04-03
PT1027895E (pt) 2008-03-18
ES2301230T3 (es) 2008-06-16
CY1107910T1 (el) 2013-09-04

Similar Documents

Publication Publication Date Title
HK1105581A1 (en) Vaccine composition
EP1176948A4 (en) COMPOSITIONS AND METHODS
HUP0002475A3 (en) Modified immunogenic pneumolysin compositions as vaccines
ZA200207589B (en) Multivalent antibodies and uses therefor. Multivalent antibodies and uses thereof.
IL148247A (en) Vaccine and its uses
EP1309602A4 (en) MALARIA IMMUNOGEN AND VACCINE
AU3760100A (en) Immunostimulatory nucleic acids and antigens
ZA200201834B (en) Vaccine against HBV and HPV.
AP2001002300A0 (en) Hiv immunogenic compositions and methods
GB9910812D0 (en) Vaccine composition
ZA976815B (en) Vaccine composition.
ZA200207002B (en) Salmonella vaccine materials and methods.
AP2002002424A0 (en) Vaccine
AU5577201A (en) Immunogenic pneumococcal protein and vaccine compositions thereof
GB9901254D0 (en) Vaccines
HK1029062A1 (en) Erysipelothrix rhusiopathiae antigens and vaccine compositions.
CZ20011896A3 (cs) Imunogenní prostředek a protilátka
ZA9710205B (en) Bacterial antigens and vaccine compositions II.
GB9906437D0 (en) Vaccine
ZA984696B (en) Vaccine compositions V.
AU3364000A (en) Antigen of erysipelothirx rhusiopathiae comprising an immuno-protective epitope
AP2002002429A0 (en) Novel composition and emulsifier
EP1071325A4 (en) COMPOSITIONS AND METHODS FOR SPECIFIC VACCINATION OF THE ANTIGEN
GB9910537D0 (en) Therapeutic antibody, Immunogenic compositions and uses
GB9929434D0 (en) Novel vaccine composition